Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"Glioblastoma Treatment"”.

  1. CD147 AS A POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA TREATMENT

    <p>Glioblastoma (GBM) tumors are the most common and lethal form of cancer in the central nervous system (CNS). GBM tumors appear to contain a mixture of different cell types, which makes them difficult to treat. GBM cells exhibit altered morphology from normal cells on several different levels, …

    nmu Repository record for CD147 AS A POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA TREATMENT (opens in a new tab)

  2. In-vitro Glioblastoma Treatment Focusing on Convection Enhanced Delivery

    Glioblastoma is a deadly brain cancer with discouraging standard of care. New methods like convection enhanced delivery and chimeric antigen receptor T cells (CAR-T) are promising treatments that can be translated to glioblastoma. In this study, CAR-T cell flow through a hydrogel was explored in …

    vt Repository record for In-vitro Glioblastoma Treatment Focusing on Convection Enhanced Delivery (opens in a new tab)

  3. Exploring Cancer Stem Cells (CSCs) pathways to design novel therapies for glioblastoma treatment

    Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in adults, with a median survival rate of 14 months (Taphoorn et al.;2005 ). GBM is characterized by rapid diffusely infiltrative growth and high level of cellular heterogeneity, which are fueled by …

    catania Repository record for Exploring Cancer Stem Cells (CSCs) pathways to design novel therapies for glioblastoma treatment (opens in a new tab)

  4. Peptide-Functionalized Layer-by-Layer Nanoparticles Demonstrate Improved Blood Brain Barrier Permeability for Glioblastoma Treatment

    The greatest obstacle in the treatment of glioblastomas is the blood-brain barrier (BBB), the endothelial cells that line the vessels of the brain and are stitched together into a barrier by tight junction complexes. One approach to overcoming this barrier is encapsulating drugs in nanoparticles …

    mit Repository record for Peptide-Functionalized Layer-by-Layer Nanoparticles Demonstrate Improved Blood Brain Barrier Permeability for Glioblastoma Treatment (opens in a new tab)

  5. THERANOSTIC PLATINUM-BASED COMPLEXES FOR GLIOBLASTOMA TREATMENT AND EVALUATION OF THEIR LOADING AND RELEASE FOR DRUG DELIVERY

    Il glioblastoma multiforme (GBM), il tumore al seno triplo negativo (TNBC) e l’adenocarcinoma duttale pancreatico (PDAC) appartengono ad una categoria di tumori conosciuta come tumori orfani. I tumori orfani sono estremamente rari, rappresentano meno dell’1% del numero totale di tumori umani, in …

    milano Repository record for THERANOSTIC PLATINUM-BASED COMPLEXES FOR GLIOBLASTOMA TREATMENT AND EVALUATION OF THEIR LOADING AND RELEASE FOR DRUG DELIVERY (opens in a new tab)

  6. Multimodal Imaging of Protein-Based Biomaterials for Delivering Chemo-Agent Cargo for Glioblastoma Treatment in a Murine Model

    … delivery carriers in a xenograft mouse model of glioblastoma multiforme (GBM).</p> <p>The primary objective was to compare the effectiveness of TRAP-loaded Dox (TRAP-DOX) to free Dox in achieving tumor extravasation and accumulation, facilitating sustained drug release. We hypothesized that the …

    cuny Repository record for Multimodal Imaging of Protein-Based Biomaterials for Delivering Chemo-Agent Cargo for Glioblastoma Treatment in a Murine Model (opens in a new tab)

  7. Polymer Nanoparticle Characterization and Applications for Drug Delivery

    … than a day, which is not conducive to long-term treatments. Controlling its release into the body over several weeks can decrease the number of doses required, which is especially useful for glioblastoma treatment. Poly(lactic-co-glycolic acid) (PLGA) is often used for drug encapsulation since it …

    vt Repository record for Polymer Nanoparticle Characterization and Applications for Drug Delivery (opens in a new tab)

  8. CHARACTERIZATION OF THERANOSTIC PEPTIDES FOR GLIOBLASTOMA MULTIFORME

    <p>Glioblastoma multiforme (GBM) is a type of primary CNS tumor in which viable treatment options do not exist. Standard of care including tumor resection, chemotherapy, and radiation does little to extend the 5-year survival expectancy past 5.1%. Herein, two small-peptide molecules with inherent …

    nmu Repository record for CHARACTERIZATION OF THERANOSTIC PEPTIDES FOR GLIOBLASTOMA MULTIFORME (opens in a new tab)